PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Go back to PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
(NASDAQ: PRCT) Delayed: 21.06 --0 (-0%)
Previous Close $21.06    52 Week High
Open $21.06    52 Week Low
Day High $21.06    P/E N/A 
Day Low $21.06    EPS
Volume 1,205